Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort.
作者信息
Bartoletti Alice, Fornara Chiara, Delvino Paolo, Franchi Giulia, Ferrari Alessandro, Baldanti Fausto, Montecucco Carlomaurizio, Monti Sara
机构信息
Department of Internal Medicine and Therapeutics, Università di Pavia, and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Department of Microbiology and Virology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
出版信息
Clin Exp Rheumatol. 2024 Apr;42(4):942. doi: 10.55563/clinexprheumatol/mlatyf. Epub 2023 Sep 15.
Abstract
摘要
相似文献
1
Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort.
Clin Exp Rheumatol. 2024 Apr;42(4):942. doi: 10.55563/clinexprheumatol/mlatyf. Epub 2023 Sep 15.
2
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response.
Emerg Microbes Infect. 2021 Dec;10(1):2235-2243. doi: 10.1080/22221751.2021.2004866.
3
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: Comment.
J Immunol Methods. 2024 Jun;529:113671. doi: 10.1016/j.jim.2024.113671. Epub 2024 Apr 7.
4
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.
Transplantation. 2021 Nov 1;105(11):e267-e269. doi: 10.1097/TP.0000000000003903.
5
Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer.
Cancer Cell. 2021 Nov 8;39(11):1445-1447. doi: 10.1016/j.ccell.2021.10.003. Epub 2021 Oct 12.
6
T-cell and Antibody Response After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients.
Transplantation. 2021 Oct 1;105(10):e142-e143. doi: 10.1097/TP.0000000000003892.
7
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy.
Clin Transl Gastroenterol. 2024 Apr 1;15(4):e00688. doi: 10.14309/ctg.0000000000000688.
8
Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients.
Cancer Cell. 2022 Mar 14;40(3):236-237. doi: 10.1016/j.ccell.2022.01.010. Epub 2022 Jan 25.
9
Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults.
Nat Microbiol. 2022 Feb;7(2):195-199. doi: 10.1038/s41564-021-01046-z. Epub 2022 Jan 10.
10
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors.
Nat Med. 2021 Nov;27(11):2002-2011. doi: 10.1038/s41591-021-01542-z. Epub 2021 Sep 30.
Zotero 插件